Pur dysgerminoma of the ovary. 12 Cases report;Les dysgerminomes ovariens purs. À propos de 12 cas

Tunisie Medicale

Volumn 81, Issue 12, 2003, Pages 937-943

  Kdous, Moez ^a   Hachicha, Rim ^a   Gamoudi, Amor ^b   Boussen, Hamouda ^c   Benna, Farouk ^d   Rahal, Khaled ^a  

^a Service de Chirurgie Carcinologique

^b Service d'Immuno Histo Cytologie   (Tunisia)

^c Service de Radiotherapie   (France)

^d SALAH AZAIEZ INSTITUTE   (Tunisia)

Author keywords

Chemotherapy; Dysgerminoma; Ovary; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINBLASTINE;

ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CLINICAL ARTICLE; DYSGERMINOMA; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; METASTASIS; OVARY TUMOR; PATHOLOGY; PHYSICAL EXAMINATION; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHEMOTHERAPY, ADJUVANT; DYSGERMINOMA; FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0742323450     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Depolo G, Pilotti S, Rotti E, Musumeci R, Mongioni C, Dire F et al. Natural history of dysgerminoma Am J Obstet Gyn. 1982; 143: 799-807.
2. Fishman DA, schwartz PE. Current approaches to diagnosis and treatment of ovarien germ cellmalignancies. Curr Opin in Obstet ond Gynecol. 1994; 6: 98-104.
3. Casey AC, Bladauria S, Shapter A, Nieberg R, Berek JS, Einsner RF. Dysgerminoma: the role of conservative surgery. Gynecol Oncol. 1996; 36: 352-357.
4. Gerhenson DM, Wharton JT, Kline RC. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential cure and preservation of reproductive capacity. Cancer 1986; 58: 2594-2599.
5. Gershenson DM, Del junco G, Copeland LJ, Rutledge FN. Mixed cell tumors of the ovary. Obstet gynecol. 1984; 64: 200-206.
6. Teinturier C, Gelez J, Flamant F, Habrand JL, Lemerle J. Pure dysgerminoma of the ovary in childhood: treatment results and sequelae. Medical and pediatric Oncology. 1994; 23: 1-7.
7. Gadduci A et al. The association of ovarien dysgerminoma and gonadoblastoma in a phenotypic femal with 46 XY koryotype.
8. Stettner AR et al. Familial ovorien germ cell cancer report and review. Am J Med Genet. 1999; 84: 43-46.
9. Ben Romdhane K, Bessrour A, Ben Amor MS, Ben Ayed M. dysgé nésie gonodique pure avec gonadoblastome dysgerminome et carcinome embryonnaire. Bull Cancer 1988; 75: 263-269.
10. About I. Molignant germ cell tumors of the ovary. J surg Oncol 1992; 62: 40-45.
11. Fleishhacker DS, Young RH. Dysgerminoma of the ovory associated with hypercalcemia. Gynecol Oncol. 1994; 52: 87-90.
12. Caubel P, Giovan Grandi V, Lasry S. Seminome et grossesse a propos d'un nouveau cas. J Gynecol Obstet Biol Reprod. 1989; 18: 487-491.
13. Wup C, Huang RL, Lang JH, Huang HF, Lian LJ, Tang MY. Treatment of malignant ovarien germ cell tumors with preservation of fertility a report of 28 cases. Gynecologic Oncology. 1991; 40: 2-6.
14. Gershenson DM. Chemotherapy of ovarien germ cell tumors and sexcord stromal tumors. Semin Surg Oncol. 1994; 10: 290-298.
15. Gerhenson DM. Updote on malignant ovarian germ cell tumors. Cancer. 1993; 71 (suppl.): 1581-1590.
16. Culine S, Lhomme C, Kattan J, Michel G, Duvillard P, Droz JP. Cisplatin based chemotherapy in the management of germ cell tumors of the ovary the institut Gustave Roussy experience. Gynecol Oncol. 1997; 64: 160-165.
17. Norris HJ, Zirkin HJ, Benson WL. Immature malignant teratoma of the ovary. A clinical and pathologic study of 58 cases. Cancer. 1976; 37: 2359-2372.
18. Coline S, Lhomme C, Droz JP. Traitement medical des tumeurs germinales de l'ovaire de l'adulte. Bull Cancer. 1997; 84: 919-921.
19. Krepart G, Smith JP, Rutledge F, Delclos L. the treatment for the dysgerminoma of the ovary. Cancer. 1978; 69: 859-864.
20. La polla JP, Benda J, Vigliotti AP, Anderson B. dysgerminoma of the ovary. Obstet gynecol. 1987; 69: 859-846.
21. Gerhenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL. Treatment of malignant germ cell tumors of the ovary with bleomycin, et oposide and cisplatine (BEP). J Clin Oncol. 1990; 8: 715-720.
22. Segelov E et al. Cisplatine based chemotherapy for ovarian germ cell malignancies the Australian experience. J Clin Oncol. 1994; 12: 378-384.
23. Gerhenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J. Clin Oncol. 1988; 6: 270-275.
24. Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP. Is there a role for second look loporotomy with management af malignant germ cell tumors of the ovary? Experience at institut gustave roussy. J Surg Oncol. 1996; 62: 40-45.
25. Williams SD, Blessiong JA, Disaia PJ, Major FJ, Ball HG, Liao SY. Second look loparotomy in ovarian germ cell tumors. The gynaecologic oncology group experience. Gynecol Oncol. 1994; 52: 287-291.
26. Talerman A. Germ cell tumors of the ovary in blaustein's pathology of the female genital tract. 4th ed. New Yor: Springer-verlag. 1995:860-874.
27. Asadourian LA, Taylor MB. Dysgerminoma an analysis of 105 cases. Obstet gynecol. 1969; 33: 370-373.
28. Schwartz PE, Chambers SK, Chambers JT, Kohorn E, Mcintosh S. Ovarian germ cell malignancies. The yele university experience. Gynecol Oncol. 1992; 45: 26-31.
29. Leblanc P, Coche-Dequeant B, Querleu D, Raviart S, Grepin G. le dysgerminome ovarien actuolité diagnostique et thérapeutique. Rev Fr Gynecol Obstet. 1988; 83: 51-61.